Press release
Artificial Intelligence (AI) In Clinical Trials Market Recent Development And Future Growth Forecast To 2033
Artificial Intelligence (AI) In Clinical Trials Market
The Business Research Company offers in-depth market insights through Artificial Intelligence AI In Clinical Trials Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The artificial intelligence (ai) in clinical trials market size has grown exponentially in recent years. It will grow from $1.52 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches.
The artificial intelligence (ai) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $4.86 billion in 2028 at a compound annual growth rate (CAGR) of 25.6%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (nlp) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12603&type=smp
Market Segmentation:
The artificial intelligence (ai) in clinical trials market covered in this report is segmented -
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users
Major Driver - Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth
The growing need to curb clinical trial costs is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Clinical trials refer to research studies used to test medical, surgical, or behavioral intervention in people, and the costs of clinical trials include the cost of the research and the cost of patient care. Drug development and other clinical trial processes are costly by nature, and artificial intelligence is used to provide better drug discovery, better designed and safer clinical trials, and improved patient outcomes at lower costs. For instance, in February 2023, according to Genetic Engineering and Biotechnology News, a US-based platform that provides the latest information on genetic engineering and biotechnology, developing a new drug among the top 20 global biopharma companies rose by 15% from $298 million in 2022 to approximately $2.3 billion in 2023, and this includes the costs incurred from developing a drug through clinical trials. Furthermore, in January 2023, according to a report published by the National Bureau of Economic Research (NBER), a US-based non-profit economic research organization, the adoption of AI within the next five years is expected to generate substantial cost savings in healthcare, ranging from 5 to 10% of healthcare spending, equating to approximately $200 billion to $360 billion in annual savings. Therefore, the growing need to curb clinical trial costs will drive artificial intelligence in the clinical trial market.
Competitive Landscape:
Major companies operating in the artificial intelligence (ai) in clinical trials market report are Medable Inc., PathAI inc., Saama Technologies Inc., Apellis Pharmaceuticals Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-clinical-trials-global-market-report
Top Trend - Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market
Innovative product offerings are a key trend in artificial intelligence in the clinical trial market. Major companies in the artificial intelligence in clinical trials market have introduced innovative product offerings to sustain their position in the market. For instance, in January 2023, Elligo Health Research Inc., a US-based healthcare-enabling research organization, launched DataAI Connect, an innovative data and technology platform that enables rapid, data-driven clinical research. The platform effortlessly gathers, manages, evaluates, and shares real-world patient data, presenting a comprehensive strategy to overcome clinical trial obstacles instead of acting as an accessory technology. This adaptable and sustainable platform includes an all-in-one solution for retrieving and evaluating medical records. It adeptly transforms data into practical insights and individual patient progress information, leveraging cutting-edge technologies such as NLP, ML, and clinical acumen.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Artificial Intelligence AI In Clinical Trials Market Characteristics
3. Artificial Intelligence AI In Clinical Trials Market Trends And Strategies
4. Artificial Intelligence AI In Clinical Trials Market - Macro Economic Scenario
5. Artificial Intelligence AI In Clinical Trials Market Size And Growth
…..
27. Artificial Intelligence AI In Clinical Trials Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence (AI) In Clinical Trials Market Recent Development And Future Growth Forecast To 2033 here
News-ID: 3434389 • Views: …
More Releases from The Business research company
Emerging Trends to Drive Recurrent Head And Neck Cancer Squamous Cell Carcinoma …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market Size Growth Forecast: What to Expect by 2025?
Significant expansion has characterized the market for squamous cell carcinoma specifically impacting the head and neck region over the past few years, moving from a valuation of $3.1 billion in 2024 to…
Rising Pneumonia Cases Fuel Demand For Advanced Treatments: Powering Innovation …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Pneumonia Therapeutics Market Through 2025?
The market encompassing pneumonia therapeutics has experienced swift expansion lately, projected to increase from a valuation of $10.35 billion in 2024 to $11.46 billion the following year, reflecting a compound annual growth rate of 10.7%. This upward…
Global Parkinson's Disease Market Expected to Achieve 8.1% CAGR by 2029: Growth …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Parkinson's Disease Market Size By 2025?
The market for treating Parkinson's disease has experienced significant expansion lately; its valuation is projected to climb from three point thirty-four billion dollars in 2024 to three point sixty-two billion dollars the following year, reflecting an eight point two…
Oral Mucositis Market Expansion Continues, with Forecast Valuation of $2.06 Bill …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Oral Mucositis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Significant upward momentum has characterized the oral mucositis market recently, projecting an expansion from its 2024 valuation of $1.44 billion to $1.55 billion by 2025, reflecting a compound annual growth rate of 7.7%. This historical…
More Releases for Trial
Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
